As of May 18
| +0.66 / +0.63%|
The 20 analysts offering 12-month price forecasts for AbbVie Inc have a median target of 110.00, with a high estimate of 157.00 and a low estimate of 81.00. The median estimate represents a +3.79% increase from the last price of 105.98.
The current consensus among 24 polled investment analysts is to Hold stock in AbbVie Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.